TrialFrontiers in endocrinology2022

Antithymocyte Globulin as Second-Line Therapy in Graves Orbitopathy-Preliminary Results From a Prospective Single-Center Study.

Monika Sarnat-Kucharczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.